Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Cureus ; 15(6): e41225, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37525763

ABSTRACT

BACKGROUND: Healthcare workers (HCWs) are critical infrastructure workers for whom COVID-19 vaccination was prioritized. It is believed that healthcare workers would have little or no hesitancy to take the COVID-19 vaccines given the risks of the pandemic to them, their families, and their patients. OBJECTIVE: The study aims to understand the acceptance and attitudes toward COVID-19 vaccines among the HCWs in Michigan. METHODS: A cross-sectional survey was fielded from January 11, 2021, through February 28, 2021. We obtained a representative sample of HCWs at MidMichigan Health. The participants were approximately 1500 clinical and non-clinical HCWs. COVID-19 vaccination acceptance and the intent to be vaccinated were measured with a questionnaire. HCWs indicating hesitance were asked to enter their reasons for hesitance as a free text response. RESULTS: A total of 1,467 HCWs responded to the survey. Overall, 62% indicated they had received both shots; 19.7% reported that they had received the first shot and would take the second; 2.3% noted that they were yet to receive the vaccine but would take both shots; 0.4% reported that they had received the first shot but would not take the second; 5.7% noted that they were unsure; and 9.9% indicated they did not intend to take the vaccine. Factors associated with vaccine hesitance included being female, younger age, having administrative staff or other health workers, having a larger household size, and having received no vaccines in the past year. Vaccine hesitancy concerns included safety, efficacy, antivaccine beliefs, the need for additional information, and a lack of trust. CONCLUSION: This survey revealed that 16% of HCWs in central and northern Michigan were hesitant about COVID-19 vaccines. Vaccine education is needed to increase the acceptance of COVID-19 vaccines among HCWs.

3.
Am J Med Sci ; 361(6): 791-794, 2021 06.
Article in English | MEDLINE | ID: mdl-33958192

ABSTRACT

Pyridoxine is an important co-factor for many biochemical reactions in cellular metabolism related to the synthesis and catabolism of amino acids, fatty acids, neurotransmitters. Deficiency of pyridoxine results in impaired transcellular signaling between neurons and presents with muscular convulsions, hyperirritability, and peripheral neuropathy. Deficiency of pyridoxine is usually found in association with other vitamin B deficiencies such as folate (vitamin B9) and cobalamin (vitamin B12). Isolated pyridoxine deficiency is extremely rare. We present the case of a 59-year old female with type 2 diabetes who complained of painful muscle spasms. Her muscle spasms involved in both feet, which have spread proximally to her legs. She also experienced intermittent muscle spasms in her left arm, which is not alleviated by baclofen, cyclobenzaprine. Her plasma pyridoxal 5-phosphate confirmed pyridoxine deficiency. Vitamins B1, B3, B12, and folate were within normal limits. The patient received standard-dose intramuscular pyridoxine injections for three weeks followed by oral supplements for 3 months and her symptoms resolved. This case illustrates the rare instance of isolated pyridoxine deficiency in type 2 diabetes patient manifesting as myoclonic muscle spasms involving the legs and arms in the absence of objective polyneuropathy. Pyridoxine level should, therefore, be assessed in patients with type 2 diabetes, including newly diagnosed patients.


Subject(s)
Diabetes Mellitus, Type 2/blood , Pyridoxine/blood , Spasm/blood , Vitamin B 6 Deficiency/blood , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/drug therapy , Diagnosis, Differential , Female , Humans , Middle Aged , Pyridoxine/administration & dosage , Pyridoxine/deficiency , Spasm/diagnosis , Spasm/drug therapy , Vitamin B 6 Deficiency/diagnosis , Vitamin B 6 Deficiency/drug therapy
4.
Environ Health ; 15: 7, 2016 Jan 19.
Article in English | MEDLINE | ID: mdl-26786592

ABSTRACT

Geoengineering is the deliberate large-scale manipulation of environmental processes that affects the Earth's climate, in an attempt to counteract the effects of climate change. Injecting sulfate aerosol precursors and designed nanoparticles into the stratosphere to (i.e., solar radiation management [SRM]), has been suggested as one approach to geoengineering. Although much is being done to unravel the scientific and technical challenges around geoengineering, there have been few efforts to characterize the potential human health impacts of geoengineering, particularly with regards to SRM approaches involving stratospheric aerosols. This paper explores this information gap. Using available evidence, we describe the potential direct occupational and public health impacts of exposures to aerosols likely to be used for SRM, including environmental sulfates, black carbon, metallic aluminum, and aluminum oxide aerosols. We speculate on possible health impacts of exposure to one promising SRM material, barium titanate, using knowledge of similar nanomaterials. We also explore current regulatory efforts to minimize exposure to these toxicants. Our analysis suggests that adverse public health impacts may reasonably be expected from SRM via deployment of stratospheric aerosols. Little is known about the toxicity of some likely candidate aerosols, and there is no consensus regarding acceptable levels for public exposure to these materials. There is also little infrastructure in place to evaluate potential public health impacts in the event that stratospheric aerosols are deployed for solar radiation management. We offer several recommendations intended to help characterize the potential occupation and public health impacts of SRM, and suggest that a comprehensive risk assessment effort is needed before this approach to geoengineering receives further consideration.


Subject(s)
Aerosols/adverse effects , Air Pollutants/adverse effects , Atmosphere/chemistry , Environmental Exposure/statistics & numerical data , Risk Assessment/statistics & numerical data , Sunlight/adverse effects , Air Pollutants/analysis , Climate Change , Geographic Information Systems/statistics & numerical data , Humans , Occupational Exposure , Particulate Matter/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...